TNF Blocker Promising for Hidradenitis Suppurativa Treatment

  The first randomized, controlled study to assess the treatment of hidradenitis suppurativa (HS) with a biologic drug shows that infliximab can safely improve disease severity, pain and quality of life. “We’re beginning to understand that HS is a closet disease. Many people have it, but it’s under-recognized, undertreated and difficult to manage,” says Francisco…

Read More

Questions or want to talk to Dr. Tahernia?

Give us a call: (310) 614-9701
Request Appointment